{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:48:21Z","timestamp":1790923701380,"version":"4.1.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":3965,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Visceral Surgery"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.jviscsurg.2010.06.004","type":"journal-article","created":{"date-parts":[[2010,7,24]],"date-time":"2010-07-24T07:15:34Z","timestamp":1279955734000},"page":"e193-e201","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Consequences of chemotherapy on resection of colorectal liver metastases"],"prefix":"10.1016","volume":"147","author":[{"given":"P.","family":"Pessaux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-P.","family":"Chenard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bachellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Jaeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jviscsurg.2010.06.004_bib1","first-page":"43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib2","first-page":"3","article-title":"Cancer incidence and mortality in France over the period 1978\u20132000","volume":"51","author":"Remontet","year":"2003","journal-title":"Rev Epidemiol Sante Publique"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/(SICI)1098-2388(199607\/08)12:4<219::AID-SSU3>3.0.CO;2-8","article-title":"Treatment of colorectal cancer: hepatic metastasis","volume":"12","author":"Fong","year":"1996","journal-title":"Semin Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00000658-198908000-00001","article-title":"Resection of hepatic metastases from colorectal carcinoma: biologic perspectives","volume":"210","author":"Steele","year":"1989","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib5","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/sj.bjc.6603033","article-title":"Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies","volume":"94","author":"Simmonds","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/bjs.1800840719","article-title":"Long-term survival following resection of colorectal hepatic metastases: Association fran\u00e7aise de chirurgie","volume":"84","author":"Jaeck","year":"1997","journal-title":"Br J Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","article-title":"Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial","volume":"371","author":"Nordlinger","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib8","doi-asserted-by":"crossref","first-page":"9441","DOI":"10.1200\/JCO.2005.04.4792","article-title":"Overall survival of patients with advanced colorectal cancer correlates with availability of fluorouracil, irinotecan, and oxaliplatin regardless of whether doublet or single-agent therapy is used first-line","volume":"23","author":"Grothey","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib9","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/bjs.4160","article-title":"Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver","volume":"90","author":"Tanaka","year":"2003","journal-title":"Br J Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib10","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2005.00.349","article-title":"Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma","volume":"23","author":"Leonard","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00000658-199610000-00009","article-title":"Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy","volume":"224","author":"Bismuth","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s10350-004-6458-8","article-title":"Evaluation of aggressively treated patients with unresectable multiple liver metastases from colorectal cancer","volume":"45","author":"Miyanari","year":"2002","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.sla.0000141198.92114.f6","article-title":"Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1023\/A:1008347829017","article-title":"Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery","volume":"10","author":"Giacchetti","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib15","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1200\/JCO.2005.07.740","article-title":"Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study","volume":"23","author":"Alberts","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib16","first-page":"268","article-title":"Triplet therapy with oxaliplatin, irinotecan, 5-fluorouracil and folinic acid within a combined modality approach in patients with liver metastases from colorectal cancer","volume":"23","author":"de la Camara","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00280-007-0588-3","article-title":"Tritherapy with fluorouracil\/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases","volume":"62","author":"Ychou","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib18","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/annonc\/mdh217","article-title":"Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients","volume":"15","author":"Pozzo","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib19","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/SLA.0b013e31819a0486","article-title":"Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil\/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases","volume":"249","author":"Masi","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib20","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/annonc\/mdi246","article-title":"Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates","volume":"16","author":"Folprecht","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib21","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1200\/JCO.2006.09.0928","volume":"25","author":"Falcone","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib22","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","article-title":"Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer","volume":"351","author":"Cunningham","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib24","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1200\/JCO.2007.10.8126","article-title":"Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy","volume":"25","author":"Adam","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib25","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa0805019","article-title":"Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer","volume":"360","author":"Van Cutsem","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib26","article-title":"Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX. FOLFIRI and fluoropyrimidines in metastatic colorectal cancer\/the BEAT study","volume":"30","author":"Van Cutsem","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1091-255X(02)00121-X","article-title":"Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases","volume":"7","author":"Allen","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib28","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/01.sla.0000145964.08365.01","article-title":"Tumor progression while on chemotherapy: a contraindication to liver resection for multiple colorectal metastases?","volume":"240","author":"Adam","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib29","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1245\/s10434-006-9068-y","article-title":"Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy","volume":"14","author":"Kornprat","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib30","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1200\/JCO.2006.06.5599","article-title":"Measures of responses: RECIST. WHO, and new alternatives","volume":"24","author":"Jaffe","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/jso.21207","article-title":"Response to chemotherapy predicts survival following resection of hepatic colorectal metastases in patients treated with neoadjuvant therapy","volume":"99","author":"Small","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/annonc\/mdl386","article-title":"Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery","volume":"18","author":"Rubbia-Brandt","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib33","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1200\/JCO.2007.13.7471","article-title":"Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality?","volume":"26","author":"Adam","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib34","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1200\/JCO.2008.17.5299","article-title":"Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases","volume":"25","author":"Blazer","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib35","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1002\/cncr.23099","article-title":"Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases","volume":"110","author":"Ribero","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib36","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1055\/s-2002-23204","article-title":"Toxic injury to hepatic sinusoids: sinusoidal obstructive syndrome (veno-occlusive disease)","volume":"22","author":"DeLeve","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib37","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/annonc\/mdh095","article-title":"Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer","volume":"15","author":"Rubbia-Brandt","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2006.05.8156","article-title":"Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases","volume":"24","author":"Aloia","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.sla.0000193603.26265.c3","article-title":"Influence of chemotherapy on the risk of major hepatectomy for colorectal liver metastases","volume":"243","author":"Karoui","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib40","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e31815774de","article-title":"Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy","volume":"247","author":"Nakano","year":"2008","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.5719","article-title":"Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases","volume":"94","author":"Zorzi","year":"2007","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.jviscsurg.2010.06.004_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jamcollsurg.2005.09.010","article-title":"Sinusoidal obstruction syndrome is a major feature of hepatic lesions associated with oxaliplatin neoadjuvant chemotherapy for liver colorectal metastases","volume":"202","author":"Rubbia-Brandt","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib43","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib44","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.510290615","article-title":"Characterization of a reproducible model of hepatic veno-occlusive disease","volume":"29","author":"DeLeve","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib45","first-page":"460","article-title":"Oxaliplatin toxicity masquerading as recurrent colon cancer","volume":"15","author":"Tisman","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib46","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for non-alcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.sla.0000193599.57858.9b","article-title":"CASH (chemotherapy-associated steatohepatitis) costs","volume":"243","author":"Fong","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib48","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jamcollsurg.2005.01.024","article-title":"Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases","volume":"200","author":"Fernandez","year":"2005","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib49","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.surg.2008.12.002","article-title":"Risk factors for chemotherapy-associated liver injuries: a multivariate analysis of a group of 146\u00a0patients with colorectal metastases","volume":"145","author":"Brouquet","year":"2009","journal-title":"Surgery"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib50","doi-asserted-by":"crossref","unstructured":"Klinger M, Eipeldauer S, Hacker S, et al. Bevacizumab protects against sinusoidal obstruction syndrome and does not increase response rate in neoajvuvant XELOX\/FOLFOX therapy of colorectal cancer liver metastases. Eur J Surg Oncol 2009:515\u201320.","DOI":"10.1016\/j.ejso.2008.12.013"},{"issue":"10","key":"10.1016\/j.jviscsurg.2010.06.004_bib51","first-page":"S26","article-title":"Cons\u00e9quences cliniques, biologiques et histologiques du cetuximab et du bevacizumab apr\u00e8s h\u00e9patectomie pour m\u00e9tastases d\u2019origine colorectale\u00a0: \u00e9tude cas-t\u00e9moin","volume":"145","author":"Panaro","year":"2008","journal-title":"J Chir"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib52","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/sj.bmt.1703061","article-title":"Vascular endothelial growth factor (VEGF) is one of the cytokines causative and predictive of hepatic veno-occlusive disease (VOD) in stem cell transplantation","volume":"27","author":"Iguchi","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib53","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0016-5085(03)01056-4","article-title":"Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition","volume":"125","author":"Deleve","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib54","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/01.SLA.0000072371.95588.DA","article-title":"Influence of transfusions on perioperative and long-term outcome in patients following resection for colorectal metastases","volume":"237","author":"Kooby","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib55","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000210025","article-title":"Adjuvant FOLFOX chemotherapy and splenomegaly in patients with stages II\u2013III colorectal cancer","volume":"76","author":"Angitapalli","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib56","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S1091-255X(98)80025-5","article-title":"Hepatic steatosis as a potential risk factor for major hepatic resection","volume":"2","author":"Berhrns","year":"1998","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1072-7515(00)00261-1","article-title":"Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection","volume":"191","author":"Belghiti","year":"2000","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib58","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1245\/s10434-006-9074-0","article-title":"Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study","volume":"14","author":"D\u2019Angelica","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib59","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jamcollsurg.2007.06.290","article-title":"Addition of bevacizumab to irinotecan and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases","volume":"206","author":"Reddy","year":"2008","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib60","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1200\/JCO.2006.05.8727","article-title":"Complete response of colorectal liver metastases after chemotherapy: does it mean cure?","volume":"24","author":"Benoist","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib61","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1177\/030089160809400408","article-title":"Complete response of colorectal liver metastases after intra-arterial chemotherapy","volume":"94","author":"Fiorentini","year":"2008","journal-title":"Tumori"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib62","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jso.20039","article-title":"Evolution of missing colorectal liver metastases following inductive chemotherapy and hepatectomy","volume":"86","author":"Elias","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib63","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1245\/s10434-007-9482-9","article-title":"Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin","volume":"14","author":"Elias","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib64","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1148\/radiol.2243011362","article-title":"Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging PET): a meta-analysis","volume":"224","author":"Kinkel","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib65","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1148\/radiol.2371042060","article-title":"Colorectal liver metastases: CT, MR imaging, and PET for diagnosis: meta-analysis","volume":"237","author":"Bipat","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0033-8389(02)00067-2","article-title":"MR imaging of liver tumors","volume":"41","author":"Kamel","year":"2003","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1053\/crad.2000.0668","article-title":"Dual phase helical CT versus portal venous phase CT for the detection of colorectal liver metastases: correlation with intra-operative sonography, surgical and pathological findings","volume":"56","author":"Scott","year":"2001","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib68","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2214\/ajr.174.3.1740691","article-title":"CT and MR imaging of hepatic metastases","volume":"174","author":"Sica","year":"2000","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib69","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s00261-007-9297-y","article-title":"Liver metastases from colorectal cancer: imaging with superparamagnetic iron oxide (SPIO)-enhanced MR imaging, computed tomography and positron emission tomography","volume":"32","author":"Rappeport","year":"2007","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib70","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1245\/s10434-009-0385-9","article-title":"Impact of chemotherapy on the accuracy of computed tomography scan for evaluation of colorectal liver metastases","volume":"16","author":"Angliviel","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib71","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s11605-006-0032-8","volume":"11","author":"Lubezky","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib72","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1259\/bjr\/29855825","article-title":"Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effects of periprocedure chemotherapy","volume":"79","author":"Beal","year":"2006","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib73","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.gassur.2005.09.001","article-title":"Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction","volume":"10","author":"Go\u00e9r\u00e9","year":"2006","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib74","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1126\/science.1079562","article-title":"Angiogenesis-independant endothelial protection of liver: role of VEGFR-1","volume":"299","author":"LeCouter","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib75","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2005.06.081","article-title":"Role of vascular endothelial growth factor pathway in tumor growth and angiogenesis","volume":"23","author":"Hicklin","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib76","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1245\/s10434-009-0447-z","article-title":"Preoperative liver hypertrophy induced by portal flow occlusion before major hepatic resection for colorectal metastases can be impaired by bevacizumab","volume":"16","author":"Aussilhou","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jviscsurg.2010.06.004_bib77","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1245\/s10434-008-0035-7","article-title":"Chemotherapy with bevacizumab does not affect liver regeneration after portal vein embolization in the treatment of colorectal liver metastases","volume":"15","author":"Zorzi","year":"2008","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Visceral Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878788610000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878788610000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:27:59Z","timestamp":1761809279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878788610000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S1878788610000408"],"URL":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2010.06.004","relation":{},"ISSN":["1878-7886"],"issn-type":[{"value":"1878-7886","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Consequences of chemotherapy on resection of colorectal liver metastases","name":"articletitle","label":"Article Title"},{"value":"Journal of Visceral Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jviscsurg.2010.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}